Downregulation of microRNA-122 promotes proliferation, migration, and invasion of human hepatocellular carcinoma cells by activating epithelial–mesenchymal transition

OncoTargets and Therapy

Volumn 9, Issue , 2016, Pages 2035-2047

  Wang, Nanyao ^a   Wang, Qiong ^a   Shen, Dong ^a   Sun, Xia ^a   Cao, Xiangming ^a   Wu, Dan ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

Epithelial mesenchymal transition; HepG2 cells; Invasion; MicroRNA 122; Migration; Proliferation; Wnt1; cadherin

Indexed keywords

MESSENGER RNA; MICRORNA 122; NERVE CELL ADHESION MOLECULE; UVOMORULIN; VIMENTIN; WNT1 PROTEIN;

ARTICLE; BETA CADHERIN GENE; CELL ACTIVATION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; E CADHERIN GENE; EPITHELIAL MESENCHYMAL TRANSITION; GENE; GENE EXPRESSION; GENE TARGETING; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; HUMAN CELL; N CADHERIN GENE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; VIMENTIN GENE; WNT1 GENE;

EID: 84964026605     PISSN: None     EISSN: 11786930     Source Type: Journal    
DOI: 10.2147/OTT.S92378     Document Type: Article

References (41)

1. Maurel M, Samali A, Chevet E. Endoplasmic reticulum stress: at the crossroads of inflammation and metabolism in hepatocellular carcinoma development. Cancer Cell. 2014;26(3):301–303.
2. Yao J, Liang L, Huang S, et al. MicroRNA-30d promotes tumor inva­sion and metastasis by targeting Galphai2 in hepatocellular carcinoma. Hepatology. 2010;51(3):846–856.
3. Wong CC, Wong CM, Tung EK, et al. The microRNA miR-139 sup­presses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2. Gastroenterology. 2011;140(1):322–331.
4. Tsai JH, Donaher JL, Murphy DA, et al. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell. 2012;22(6):725–736.
5. Li S, Mo C, Peng Q, et al. Cell surface glycan alterations in epithelial mesenchymal transition process of Huh7 hepatocellular carcinoma cell. PLoS One. 2013;8(8):e71273.
6. Zheng F, Liao YJ, Cai MY, et al. The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut. 2012;61(2):278–289.
7. Ceppi P, Peter ME. MicroRNAs regulate both epithelial-to-mesenchymal transition and cancer stem cells. Oncogene. 2014;33(3):269–278.
8. Hur K, Toiyama Y, Takahashi M, et al. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis. Gut. 2013;62(9):1315–1326.
9. Kumarswamy R, Mudduluru G, Ceppi P, et al. MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer. Int J Cancer. 2012;130(9):2044–2053.
10. Ding XM. MicroRNAs: regulators of cancer metastasis and epithelial-mesenchymal transition (EMT). Chin J Cancer. 2014;33(3):140–147.
11. Stahlhut Espinosa CE, Slack FJ. The role of microRNAs in cancer. Yale J Biol Med. 2006;79(3–4):131–140.
12. Yang F, Zhang L, Wang F, et al. Modulation of the unfolded protein response is the core of microRNA-122-involved sensitivity to chemother­apy in hepatocellular carcinoma. Neoplasia. 2011;13(7):590–600.
13. Coulouarn C, Factor VM, Andersen JB, et al. Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene. 2009;28(40):3526–3536.
14. Sendi H. Dual role of miR-122 in molecular pathogenesis of viral hepatitis. Hepat Mon. 2012;12(5):312–314.
15. Ma D, Tao X, Gao F, et al. miR-224 functions as an onco-miRNA in hepatocellular carcinoma cells by activating AKT signaling. Oncol Lett. 2012;4(3):483–488.
16. Watanabe K, Harada-Shiba M, Suzuki A, et al. In vivo siRNA delivery with dendritic poly(L-lysine) for the treatment of hypercholesterolemia. Mol Biosyst. 2009;5(11):1306–1310.
17. Ye RS, Xi QY, Qi Q, et al. Differentially expressed miRNAs after GnRH treatment and their potential roles in FSH regulation in porcine anterior pituitary cell. PLoS One. 2013;8(2):e57156.
18. Yan GN, Lv YF, Yang L, et al. Glioma stem cells enhance endothelial cell migration and proliferation via the Hedgehog pathway. Oncol Lett. 2013;6(5):1524–1530.
19. Su Y, Ni Z, Wang G, et al. Aberrant expression of microRNAs in gastric cancer and biological significance of miR-574-3p. Int Immunopharmacol. 2012;13(4):468–475.
20. Chen L, Guan H, Gu C, et al. miR-383 inhibits hepatocellular carci­noma cell proliferation via targeting APRIL. Tumour Biol. Epub 2015 Sept 15.
21. Li Q, Wang G, Shan JL, et al. MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion. J Gastroenterol Hepatol. 2010;25(1):164–171.
22. Sun Z, Meng C, Wang S, et al. MicroRNA-1246 enhances migration and invasion through CADM1 in hepatocellular carcinoma. BMC Cancer. 2014;14:616.
23. Wolfe A, Thomas A, Edwards G, et al. Increased activation of the Wnt/β-catenin pathway in spontaneous hepatocellular carcinoma observed in farnesoid X receptor knockout mice. J Pharmacol Exp Ther. 2011;338(1):12–21.
24. Turato C, Simonato D, Quarta S, et al. MicroRNAs and SerpinB3 in hepatocellular carcinoma. Life Sci. 2014;100(1):9–17.
25. Xu J, Zhu X, Wu L, et al. MicroRNA-122 suppresses cell prolifera­tion and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β-catenin pathway. Liver Int. 2012;32(5):752–760.
26. Wu X, Wu S, Tong L, et al. miR-122 affects the viability and apoptosis of hepatocellular carcinoma cells. Scand J Gastroenterol. 2009;44(11):1332–1339.
27. Tsai WC, Hsu SD, Hsu CS, et al. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J Clin Invest. 2012;122(8):2884–2897.
28. Nagai T, Arao T, Furuta K, et al. Sorafenib inhibits the hepatocyte growth factor-mediated epithelial mesenchymal transition in hepatocel­lular carcinoma. Mol Cancer Ther. 2011;10(1):169–177.
29. Jou J, Diehl AM. Epithelial-mesenchymal transitions and hepatocar­cinogenesis. J Clin Invest. 2010;120(4):1031–1034.
30. Yang J, Weinberg RA. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell. 2008;14(6):818–829.
31. Zhou X, Hu Y, Dai L, et al. MicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT/ERK1/2 inactivation by targeting EGFR in epithelial ovarian cancer. PLoS One. 2014;9(5):e96718.
32. Jing Y, Han Z, Liu Y, et al. Mesenchymal stem cells in inflam­mation microenvironment accelerates hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition. PLoS One. 2012;7(8):e43272.
33. Lee JY, Park MK, Park JH, et al. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer. Oncogene. 2014;33(10):1325–1335.
34. Sobrado VR, Moreno-Bueno G, Cubillo E, et al. The class I bHLH factors E2-2A and E2-2B regulate EMT. J Cell Sci. 2009;122(Pt 7):1014–1024.
35. Howard S, Deroo T, Fujita Y, et al. A positive role of cadherin in Wnt/β-catenin signalling during epithelial-mesenchymal transition. PLoS One. 2011;6(8):e23899.
36. Huang J, Xiao D, Li G, et al. EphA2 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer cells. Oncogene. 2014;33(21):2737–2747.
37. Giangreco A, Lu L, Vickers C, et al. β-Catenin determines upper airway progenitor cell fate and preinvasive squamous lung cancer progression by modulating epithelial-mesenchymal transition. J Pathol. 2012;226(4):575–587.
38. Zhang Q, Bai X, Chen W, et al. Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocel­lular carcinoma via crosstalk with hif-1α signaling. Carcinogenesis. 2013;34(5):962–973.
39. MacDonald BT, Tamai K, He X. Wnt/β-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009;17(1):9–26.
40. Sanchez-Tillo E, de Barrios O, Siles L, et al. β-Catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness. Proc Natl Acad Sci U S A. 2011;108(48):19204–19209.
41. Wang SC, Lin XL, Li J, et al. MicroRNA-122 triggers mesenchymal-epithelial transition and suppresses hepatocellular carcinoma cell motility and invasion by targeting RhoA. PLoS One. 2014;9(7):e101330.